With all due respect, perhaps you missed the fact that the bio sector was
rallying like crazy or the fact that ABBV was oversold ?
ABBV share price will decline as the deal gets closer to closing. Why ?
Because they will be assuming dilution .
I might be wrong, but ,considering that all BOD's voted yes to this and the
agents who put together this deal are industry bigs, I consider it done .
Also, please note that the offer was a nice premium .
We all might have wanted more but this is the real world and market
conditions are more unpredictable than ever.
I'm old enough to recall the days of a 'take under' vs a 'take over' , sadly !